PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
42.82M
Better than INKT's estimated revenue of 16.50M.
-8.56M
Worse than INKT's estimated ebitda of 13.16M.
-0.59
Better than INKT's estimated eps of -2.54.
-17.89M
Worse than INKT's estimated net income of -9.58M.
-8.56M
Worse than INKT's estimated ebit of 13.16M.
1.59B
Worse than INKT's estimated sg&a expense of 13.21M.
Analyze DCF forecasts for the company and compare them with competitors.
No Data
No DCF data available for this metric in the selected year.
-100.00%
Worse than INKT's revenue growth rate of 0.00%.
-37.43M
Worse than INKT's ebitda of -10.57M.
100.00%
Equal to INKT's ebitda margin of 100.00%.
-38.24M
Worse than INKT's ebit of -10.78M.
100.00%
Equal to INKT's ebit margin of 100.00%.
811.00K
Worse than INKT's depreciation of 215.44K.
72.90M
Better than INKT's total cash of 4.58M.
100.00%
Equal to INKT's cash as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Equal to INKT's receivables as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Equal to INKT's inventories as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
100.00%
Equal to INKT's payables as percentage of revenue of 100.00%.
-11.00K
Better than INKT's capital expenditure of 0.00.
100.00%
Equal to INKT's capex as percentage of revenue of 100.00%.
4.99%
Worse than INKT's weighted average cost of capital (wacc) of 4.86%.
5.02%
Worse than INKT's cost of equity of 5.00%.
4.08%
Worse than INKT's cost of debt of 4.06%.
-0.23
Better than INKT's beta of 0.16.
30.07M
Worse than INKT's diluted shares outstanding of 3.77M.
1.57M
Better than INKT's total debt of 4.92M.
49.31M
Better than INKT's total equity of 28.26M.
50.89M
Better than INKT's total capital of 33.19M.
3.09%
Better than INKT's debt weighting of 14.84%.
96.91%
Better than INKT's equity weighting of 85.16%.
-38.24M
Worse than INKT's ebiat of -10.78M.
-45.40M
Worse than INKT's unlevered free cash flow of -11.75M.
2.00%
Equal to INKT's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than INKT's net debt of 347.57K.
71.33M
Better than INKT's equity value of -2.95M.
2.37
Better than INKT's equity value per share of -0.78.